Drugs.com - New Drug Approvals

FDA Approves Nuvaxovid (COVID-19 Vaccine, Adjuvanted) to Prevent COVID-19

GAITHERSBURG, Md., May 19, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™ for active immunization to...

May 21, 2025 - 01:30
 0
FDA Approves Nuvaxovid (COVID-19 Vaccine, Adjuvanted) to Prevent COVID-19
GAITHERSBURG, Md., May 19, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™ for active immunization to...
Read More

Tags:

Previous Article

VC-Backed Modern Incontinence Brand Hazel Launches At Target

Next Article

Adding Team Therapist Reduces Burnout for Critical Care Nurses

Related Posts

FDA Grants Accelerated Approval for Vanrafia (atrasenta...

May 12, 2025  0

FDA Approves an Updated Label for Tryvio (aprocitentan)...

May 12, 2025  0

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Xeris Announces Approval of Supplemental New Drug Appli...

May 13, 2025  0